Cargando…
Lactoferrin-Conjugated Nanoparticles as New Antivirals
Lactoferrin is an iron-binding glycoprotein with multiple functions in the body. Its activity against a broad spectrum of both DNA and RNA viruses as well as the ability to modulate immune responses have made it of interest in the pharmaceutical and food industries. The mechanisms of its antiviral a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504495/ https://www.ncbi.nlm.nih.gov/pubmed/36145610 http://dx.doi.org/10.3390/pharmaceutics14091862 |
_version_ | 1784796231238680576 |
---|---|
author | Krzyzowska, Malgorzata Janicka, Martyna Tomaszewska, Emilia Ranoszek-Soliwoda, Katarzyna Celichowski, Grzegorz Grobelny, Jarosław Szymanski, Pawel |
author_facet | Krzyzowska, Malgorzata Janicka, Martyna Tomaszewska, Emilia Ranoszek-Soliwoda, Katarzyna Celichowski, Grzegorz Grobelny, Jarosław Szymanski, Pawel |
author_sort | Krzyzowska, Malgorzata |
collection | PubMed |
description | Lactoferrin is an iron-binding glycoprotein with multiple functions in the body. Its activity against a broad spectrum of both DNA and RNA viruses as well as the ability to modulate immune responses have made it of interest in the pharmaceutical and food industries. The mechanisms of its antiviral activity include direct binding to the viruses or its receptors or the upregulation of antiviral responses by the immune system. Recently, much effort has been devoted to the use of nanotechnology in the development of new antivirals. In this review, we focus on describing the antiviral mechanisms of lactoferrin and the possible use of nanotechnology to construct safe and effective new antiviral drugs. |
format | Online Article Text |
id | pubmed-9504495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95044952022-09-24 Lactoferrin-Conjugated Nanoparticles as New Antivirals Krzyzowska, Malgorzata Janicka, Martyna Tomaszewska, Emilia Ranoszek-Soliwoda, Katarzyna Celichowski, Grzegorz Grobelny, Jarosław Szymanski, Pawel Pharmaceutics Review Lactoferrin is an iron-binding glycoprotein with multiple functions in the body. Its activity against a broad spectrum of both DNA and RNA viruses as well as the ability to modulate immune responses have made it of interest in the pharmaceutical and food industries. The mechanisms of its antiviral activity include direct binding to the viruses or its receptors or the upregulation of antiviral responses by the immune system. Recently, much effort has been devoted to the use of nanotechnology in the development of new antivirals. In this review, we focus on describing the antiviral mechanisms of lactoferrin and the possible use of nanotechnology to construct safe and effective new antiviral drugs. MDPI 2022-09-03 /pmc/articles/PMC9504495/ /pubmed/36145610 http://dx.doi.org/10.3390/pharmaceutics14091862 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Krzyzowska, Malgorzata Janicka, Martyna Tomaszewska, Emilia Ranoszek-Soliwoda, Katarzyna Celichowski, Grzegorz Grobelny, Jarosław Szymanski, Pawel Lactoferrin-Conjugated Nanoparticles as New Antivirals |
title | Lactoferrin-Conjugated Nanoparticles as New Antivirals |
title_full | Lactoferrin-Conjugated Nanoparticles as New Antivirals |
title_fullStr | Lactoferrin-Conjugated Nanoparticles as New Antivirals |
title_full_unstemmed | Lactoferrin-Conjugated Nanoparticles as New Antivirals |
title_short | Lactoferrin-Conjugated Nanoparticles as New Antivirals |
title_sort | lactoferrin-conjugated nanoparticles as new antivirals |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504495/ https://www.ncbi.nlm.nih.gov/pubmed/36145610 http://dx.doi.org/10.3390/pharmaceutics14091862 |
work_keys_str_mv | AT krzyzowskamalgorzata lactoferrinconjugatednanoparticlesasnewantivirals AT janickamartyna lactoferrinconjugatednanoparticlesasnewantivirals AT tomaszewskaemilia lactoferrinconjugatednanoparticlesasnewantivirals AT ranoszeksoliwodakatarzyna lactoferrinconjugatednanoparticlesasnewantivirals AT celichowskigrzegorz lactoferrinconjugatednanoparticlesasnewantivirals AT grobelnyjarosław lactoferrinconjugatednanoparticlesasnewantivirals AT szymanskipawel lactoferrinconjugatednanoparticlesasnewantivirals |